BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Treatment
522 results:

  • 1. KIF3C: an emerging biomarker with prognostic and immune implications across pan-cancer types and its experiment validation in gastric cancer.
    Zhong Q; Hong W; Xiong L
    Aging (Albany NY); 2024 Mar; 16(7):6163-6187. PubMed ID: 38552217
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Nobiletin targets SREBP1/ACLY to induce autophagy-dependent cell death of gastric cancer cells through pi3k/Akt/mTOR signaling pathway.
    Chen M; Li H; Zheng S; Shen J; Chen Y; Li Y; Yuan M; Wu J; Sun Q
    Phytomedicine; 2024 Jun; 128():155360. PubMed ID: 38547624
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Myotubularin-related-protein-7 inhibits mutant (G12V) K-RAS by direct interaction.
    Weidner P; Saar D; Söhn M; Schroeder T; Yu Y; Zöllner FG; Ponelies N; Zhou X; Zwicky A; Rohrbacher FN; Pattabiraman VR; Tanriver M; Bauer A; Ahmed H; Ametamey SM; Riffel P; Seger R; Bode JW; Wade RC; Ebert MPA; Kragelund BB; Burgermeister E
    Cancer Lett; 2024 Apr; 588():216783. PubMed ID: 38462034
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Investigation on the mechanism of the combination of eremias multiocellata and cisplatin in reducing chemoresistance of gastric cancer based on
    Cheng FE; Li Z; Bai X; Jing Y; Zhang J; Shi X; Li T; Li W
    Aging (Albany NY); 2024 Feb; 16(4):3386-3403. PubMed ID: 38345573
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Diterpenoid tanshinones inhibit gastric cancer angiogenesis through the pi3k/Akt/mTOR signaling pathway.
    Yu JR; Liu YY; Gao YY; Qian LH; Qiu JL; Wang PP; Zhang GJ
    J Ethnopharmacol; 2024 Apr; 324():117791. PubMed ID: 38301987
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [High expression of CPNE3 correlates with poor long-term prognosis of gastric cancer by inhibiting cell apoptosis
    Duan T; Zhang Z; Shi J; Xiao L; Yang J; Yin L; Zhang X; Geng Z; Lu G
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jan; 44(1):129-137. PubMed ID: 38293984
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Efficacy of Tounongsan decoction on pyogenic liver abscess: network pharmacology and clinical trial validation.
    Qi Z; Dexuan C; Guixiang Z; Shihu Z; Xiao F; Chaoqun MA; Yi Z
    J Tradit Chin Med; 2024 Feb; 44(1):145-155. PubMed ID: 38213249
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. PHB2 promotes SHIP2 ubiquitination via the E3 ligase NEDD4 to regulate AKT signaling in gastric cancer.
    Xu L; Xiang W; Yang J; Gao J; Wang X; Meng L; Ye K; Zhao XH; Zhang XD; Jin L; Ye Y
    J Exp Clin Cancer Res; 2024 Jan; 43(1):17. PubMed ID: 38200519
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Study on the Role and Mechanism of METTL3 Mediating the Up-regulation of 
m6A Modified Long Non-coding RNA THAP7-AS1 in Promoting the Occurrence of 
Lung cancer].
    Zhang Y; Wang Y; Liu M
    Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):919-933. PubMed ID: 38163978
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Dual pi3k/mTOR inhibitor PF-04979064 regulates tumor growth in gastric cancer and enhances drug sensitivity of gastric cancer cells to 5-FU.
    Zhong Z; Wang T; Zang R; Zang Y; Feng Y; Yan S; Geng C; Zhu N; Wang Q
    Biomed Pharmacother; 2024 Jan; 170():116086. PubMed ID: 38159377
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The role of α7-nAChR-mediated pi3k/AKT pathway in lung cancer induced by nicotine.
    He Z; Xu Y; Rao Z; Zhang Z; Zhou J; Zhou T; Wang H
    Sci Total Environ; 2024 Feb; 912():169604. PubMed ID: 38157907
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Modified Chaishao Liujunzi Decoction inhibits bile acid-induced gastric intestinal metaplasia: from network prediction to experimental verification.
    Sun Z; Liu Y; Deng H; Wang S; Zhang J; Xing C; Xu C
    Aging (Albany NY); 2023 Dec; 15(23):13998-14018. PubMed ID: 38096029
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The genomic and immune landscapes of gastric cancer and their correlations with HER2 amplification and PD-L1 expression.
    Jing X; Luo Z; Wu J; Ye F; Li J; Song Z; Zhang Y; Shi M; Sun H; Fang Y; Jiang Y; Ji X
    Cancer Med; 2023 Dec; 12(24):21905-21919. PubMed ID: 38050871
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Advances in RNAi therapies for gastric cancer: Targeting drug resistance and nanoscale delivery.
    Hashemi M; Aparviz R; Beickzade M; Paskeh MDA; Kheirabad SK; Koohpar ZK; Moravej A; Dehghani H; Saebfar H; Zandieh MA; Salimimoghadam S; Rashidi M; Taheriazam A; Entezari M; Samarghandian S
    Biomed Pharmacother; 2023 Dec; 169():115927. PubMed ID: 38006616
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Compound-composed Chinese medicine of Huachansu triggers apoptosis of gastric cancer cells through increase of reactive oxygen species levels and suppression of proteasome activities.
    Deng YQ; Gao M; Lu D; Liu QP; Zhang RJ; Ye J; Zhao J; Feng ZH; Li QZ; Zhang H
    Phytomedicine; 2024 Jan; 123():155169. PubMed ID: 37992493
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Investigating the therapeutic mechanism of Xiaotan Sanjie Formula for gastric cancer via network pharmacology and molecular docking: A review.
    Xu X; Yu Z; Zeng S
    Medicine (Baltimore); 2023 Nov; 102(46):e35986. PubMed ID: 37986339
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
    Sohel M
    Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Ranitidine as an adjuvant regulates macrophage polarization and activates CTLs through the pi3k-Akt2 signaling pathway.
    Li C; Wang S; Ma X; Wang T; Lu R; Jia X; Leng Z; Kong X; Zhang J; Li L
    Int Immunopharmacol; 2023 Mar; 116():109729. PubMed ID: 37800555
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The molecular targets of Kangai injection in gastric cancer by in silico network pharmacology approach and experiment confirmation.
    Qiu Y; Huang S; Zhu M
    J Appl Biomed; 2023 Sep; 21(3):150-159. PubMed ID: 37747314
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Mechanism of Quercetin as a Multidrug-resistant Reversing Compound in Oxaliplatin-resistant gastric-cancer Cell Lines.
    Zhao G; Xue S
    Altern Ther Health Med; 2023 Nov; 29(8):54-59. PubMed ID: 37652429
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 27.